Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
111in-j591 (1 trial)
aldesleukin (Proleukin) (1 trial)
Prostatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)